Library
اللاد
AL-LAD is a semi-synthetic psychedelic of the lysergamide class and a close structural analog of LSD. First described in scientific literature during the 1970s, it was further investigated by Andrew J. Hoffman and David Nichols in 1984 and subsequently documented by Alexander Shulgin in TiHKAL. It entered the research chemical market around 2013 as a grey-market alternative to LSD. Users often report enhanced visual activity with comparatively reduced cognitive intensity relative to LSD.
Also known as: Aladdin, N-allyl-nor-lsd, 6-allyl-6-nor-lsd, N6-allyl-nor-LSD
Classification
- Chemical: Lysergamide
- Psychoactive: Psychedelic
- Tag: Research-Chemical
Effects
- Spontaneous Tactile Sensations
- Stimulation
- Nausea
- Increased Heart Rate
- Pupil Dilation
- Difficulty Urinating
- Time Distortion
- Introspection
- Multiple Thought Streams
- Conceptual Thinking
- Ego Suppression Loss And Death
- Thought Loop
- Hallucinations
- Visual Drifting
- Tracers
- After Images
- Symmetrical Texture Repetition
- Color Shifting
Routes of Administration
Oral
Dosage
- Heavy: 300–350+ µg
- Light: 20 – 75 µg
- Common: 75 – 175 µg
- Strong: 175 – 250 µg
- Threshold: 20 ug
Duration
- Onset: 0.5-1.5 h
- Comeup: 0.5-1 h
- Peak: 2.5-5 h
- Offset: 2-3 h
- After Effects: 2-18 h
- Total Duration: 6-8 h
Sublingual
Dosage
- Heavy: 300–350+ µg
- Light: 40–60 µg
- Common: 75–150 µg
- Strong: 175–250 µg
- Threshold: 20 µg
Duration
No data available for this section yet.
Harm Reduction
Check interactions before mixing substances, pay attention to dose spacing and hydration, and treat all dosage guidance as approximate rather than guaranteed safe.
Sources
Substance data is aggregated from the following public harm-reduction and reference sources.
Links
This static page is intended as a readable non-JS and prerender-friendly library export.
